Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

OWP
FDA Approves SUBVENITE — OWP Pharmaceuticals, Inc.

OWP Pharmaceuticals, Inc. received FDA approval on September 16, 2025, for its generic version of the antiepileptic drug LAMOTRIGINE targeting epileps...

AstraZeneca
FDA Approves KOSELUGO — AstraZeneca Pharmaceuticals LP

# FDA Approves AstraZeneca's KOSELUGO (selumetinib) for Neurofibromatosis Type 1 AstraZeneca Pharmaceuticals LP has received FDA approval for KOSELUG...

Eisai
FDA Approves LECANEMAB AUTOINJECTOR — Eisai Inc.

Eisai Inc. announced Friday the FDA approval of the subcutaneous lecanemab (Leqembi) formulation, expanding the treatment accessibility for early Alzh...

VALIDUS
FDA Approves LOPRESSOR — VALIDUS PHARMACEUTICALS LLC

On August 28, 2025, Validus Pharmaceuticals received FDA approval for Lopressor (metoprolol tartrate), which the company characterized as a substantia...

First
FDA Approves DIVALPROEX SODIUM — First Nation Group, LLC

First Nation Group, LLC secured FDA approval for its generic version of DIVALPROEX SODIUM on August 12, 2025, targeting the oral formulation previousl...

Boehringer
FDA Approves HERNEXEOS — Boehringer Ingelheim Pharmaceuticals, Inc.

# FDA Approves Boehringer Ingelheim's HERNEXEOS (Zongertinib) for Oral Administration Boehringer Ingelheim Pharmaceuticals has received FDA approval ...

Camber
FDA Approves VORICONAZOLE — Camber Pharmaceuticals, Inc.

The FDA on August 8, 2025, approved Voriconazole Oral Suspension (ANDA211598) from Camber Pharmaceuticals, Inc., positioning the company to capture si...

STALLION
FDA Approves GABAPENTIN — STALLION LABORATORIES PRIVATE LIMITED

Following the FDA’s August 7 approval of generic Gabapentin, Stallion Laboratories Private Limited adds a new player to a crowded and highly competiti...

Camber
FDA Approves SPIRONOLACTONE — Camber Pharmaceuticals, Inc.

# FDA Approves Spironolactone Generic from Camber Pharmaceuticals Camber Pharmaceuticals, Inc. received FDA approval for its generic spironolactone o...

Alembic
FDA Approves CARBAMAZEPINE — Alembic Pharmaceuticals Inc.

Alembic Pharmaceuticals Inc. secured FDA approval on July 25, 2025, for its generic Carbamazepine oral tablet, enabling the company to expand its mark...

LEO
FDA Approves ANZUPGO — LEO Pharma, Inc

LEO Pharma, Inc. received FDA approval for the topical delgocitinib formulation under the brand name ANZUPGO, marking a strategic expansion of its por...

DR
FDA Approves Unknown Drug — DR REDDYS LABS SA

DR REDDYS LABS SA has secured FDA approval for its Abbreviated New Drug Application (ANDA215276), signaling a pivotal expansion of its generic portfol...

RENGENERON
FDA Approves Unknown Drug — RENGENERON PHARMACEUTICALS, INC.

Renegeron Pharmaceuticals, Inc. has achieved a pivotal approval, according to the U.S. Food and Drug Administration, with market implications expected...

Alembic
FDA Approves DOXORUBICIN HYDROCHLORIDE — Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited announced on Friday, June 27, 2025, the approval of an ANDA by the U.S. FDA for doxorubicin hydrochloride injection, a...

TP
FDA Approves Unknown Drug — TP ANDA HOLDINGS

# FDA Approves ANDA Application for TP ANDA Holdings TP ANDA Holdings received FDA approval for ANDA219509 on June 23, 2025, potentially strengthenin...

Dr.Reddys
FDA Approves PHENTERMINE AND TOPIRAMATE EXTENDED-RELEASE — Dr.Reddys Laboratories Inc

Dr. Reddys Laboratories Inc. has secured FDA approval for its ANDA82176 generic version of Qsymia (phentermine and topiramate extended-release), enter...

NUVATION
FDA Approves Unknown Drug — NUVATION

NUVATION BIO announced Tuesday that the FDA has accepted its new drug application for its lead immune-oncology asset, a critical step that catalyzes t...

Fresenius
FDA Approves ROCURONIUM — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC announced on June 9 a new FDA approval for rocuronium bromide, potentially revitalizing the generic neuromuscular blockers mar...

Azurity
FDA Approves WIDAPLIK — Azurity Pharmaceuticals, Inc.

Azurity Pharmaceuticals secured FDA approval Friday for WIDAPLIK (telmisartan, amlodipine and indapamide), a new oral antihypertensive. This launch st...

Devatis
FDA Approves LENALIDOMIDE — Devatis Inc.

Devatis Inc. secured FDA approval for its oral Lenalidomide generic, positioning the manufacturer to capture potential market share in the myeloma tre...